@conference{9bcbfcbb4f1248f4af742aa675738f1b,
title = "ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA",
author = "Christina Tsien and Stephanie Pugh and adam Dicker and Jeffrey Raizer and Martha Matuszak and Enrico Lallana and Jiayi Huang and ozer algan and Nicholas Taylor and Lorraine Portelance and John Villano and Hamm, \{John T\} and Oh, \{Kevin S\} and Ali, \{Arif N\} and Michelle Kim and Scott Lindhorst and Minesh Mehta",
note = "You do not currently have access to this article. Subscription prices and ordering ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA - 24 Hours access; Neuro-oncology ; Conference date: 11-11-2019",
year = "2019",
month = nov,
day = "11",
doi = "10.1093/neuonc/noz175.075",
language = "American English",
}